Atrial fibrillation in hypertrophic cardiomyopathy: mechanisms, embolic risk and prognosis.
Hypertrophic cardiomyopathy (HCM) is associated with an increased incidence of supraventricular and ventricular arrhythmias. Atrial fibrillation (AF) is the most common arrhythmia in HCM with a prevalence of 20% and an annual incidence of two percent per year. Increased left atrial size and volume along with impaired left atrial function confer an increased likelihood of AF. The onset of AF is often accompanied by a decrease in functional status in conjunction with an increased risk of stroke and overall mortality.
Nair
Ajith G
AG
Zena and Michael A. Weiner Cardiovascular Institute, Mount Sinai Medical Center, New York, NY, USA.
Fischer
Avi G
AG
D001281:Atrial Fibrillation / Q000150:complications*; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications / Q000401:mortality*; D006801:Humans; D012720:Severity of Illness Index; D016019:Survival Analysis